Inandex

Dexamethasone phosphate, the active ingredient in Inandex, is a corticosteroid presented as a sterile injectable solution for infiltration, intramuscular or intravenous use. It is employed to reduce inflammation and modulate immune responses in patients with various inflammatory, allergic and endocrine conditions.

GNH USA supplies Inandex as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Inandex, a glucocorticoid, is used to manage disorders driven by inflammation or immune dysregulation.

- Inflammatory disorders: reduces swelling, pain and tissue damage. - Allergic reactions: suppresses acute and chronic hypersensitivity responses. - Autoimmune diseases: dampens aberrant immune activity to limit organ injury. - Adrenal insufficiency: provides glucocorticoid replacement when endogenous production is inadequate.

Adverse reactions may vary with dose, duration and route of administration.

Common Side Effects: - Hyperglycemia: elevated blood glucose levels, especially in diabetic patients. - Increased appetite and weight gain. - Insomnia or mood swings. - Injection‑site pain or erythema. - Fluid retention and mild edema. - Gastro‑intestinal discomfort.

Serious or Rare Side Effects: - Adrenal suppression leading to crisis on abrupt discontinuation. - Severe infections due to immunosuppression. - Gastrointestinal bleeding or ulceration. - Psychosis or severe mood disturbances. - Anaphylactic reactions. - Osteonecrosis of the jaw or long bones.

Before initiating therapy, clinicians should evaluate patient‑specific risk factors and monitor for potential complications.

- Blood glucose monitoring: adjust antidiabetic therapy as needed. - Infection surveillance: avoid use in uncontrolled systemic infections. - Electrolyte balance: watch for hypokalemia and sodium retention. - Dose minimisation: use the lowest effective dose for the shortest duration. - Tapering plan: gradually reduce dose to prevent adrenal insufficiency. - Store at ambient temperature: keep in original container, protect from moisture and light.

Dexamethasone phosphate can alter the pharmacokinetics or pharmacodynamics of several agents.

Major Interactions (Avoid): - Strong CYP3A4 inhibitors (e.g., ketoconazole, clarithromycin): may increase systemic exposure. - Live vaccines: risk of attenuated pathogen proliferation. - Antifungal azoles (e.g., itraconazole): potentiate glucocorticoid effects.

Moderate Interactions (Monitor Closely): - Anticoagulants (warfarin): may enhance anticoagulant effect, requiring INR monitoring. - Antidiabetic drugs (insulin, oral hypoglycemics): may require dose adjustment due to hyperglycemia. - Non‑steroidal anti‑inflammatory drugs (NSAIDs): increased risk of gastrointestinal ulceration.